Clinical Trials Directory

Trials / Completed

CompletedNCT00000292

Acute Withdrawal From Smoked Cocaine - 9

Acute Withdrawal From Smoked Cocaine

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop an experimental paradigm to examine acute withdrawal symptoms from cocaine.

Detailed description

Although there are clearly identifiable withdrawal syndromes following cessation of a number of abused drugs such as alcohol and heroin, it is unclear whether a withdrawal syndrome follows the cessation of crack cocaine. A laboratory model of withdrawal from smoked (crack) cocaine would provide a safe and systematic method of testing the efficacy of behavioral or pharmacological treatments for withdrawal symptoms following cocaine smoking cessation. Therefore, this study investigated acute behavioral, subjective, and physiological withdrawal symptomatology for 6 hrs following 7 deliveries of 2 dose sized (0.07 vs. 0.4 mg/kg) of smoked cocaine. The behavioral measure was performance on a computerized reaction time task, subjective measures included participant and observer ratings of mood and withdrawal symptomatology, and physiological measures comprised heart rate and blood pressure. It was hypothesized that signs and symptoms of withdrawal from smoked cocaine would be greater following the 0.4 mg/kg dose size, compared to the 0.07 mg/kg dose size.

Conditions

Interventions

TypeNameDescription
PROCEDURECocaine

Timeline

Start date
1996-04-01
Completion
2001-12-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000292. Inclusion in this directory is not an endorsement.